Glenmark Pharmaceuticals
- All
- News
- Videos
-
Glenmark Pharma To Sell 75% Stake In Life Sciences To Nirma For $680 Million
Drugmaker Glenmark Pharmaceuticals said on Thursday it would sell a 75% stake in unit Glenmark Life Sciences to detergent maker Nirma for 56.52 billion rupees ($679.84 million).
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Glenmark Pharmaceuticals Gets Final US Approval For Lacosamide Tablet
Homegrown pharma major Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Lacosamide tablet, indicated for prevention and control of seizures.
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
Glenmark Life Sciences IPO Subscribed Nearly 45 Times On Final Day Of Issue
Glenmark Life Sciences' share sale via initial public offering (IPO) was subscribed by 44.17 times on Thursday, July 29- the third and final day of its issue.
-
Glenmark Life Sciences IPO Opens Today
Glenmark Life Sciences IPO, which will be open for three days until July 29, will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares
-
Glenmark Life Sciences IPO To Open Tomorrow. Should You Subscribe?
Glenmark Life Sciences' IPO will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares by Glenmark Pharmaceuticals
-
Glenmark Life Sciences IPO To Open On July 27. Here's All You Need To Know
Glenmark Life Sciences' IPO will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares by Glenmark Pharmaceuticals
-
Stocks To Watch: HDFC Bank, Wipro, Bank of Baroda
The Reserve Bank of India has imposed a Rs 10 crore penalty on HDFC Bank in relation to marketing and sale of third-party non-financial products to customers, HDFC Bank said
-
Glenmark Arm Files Papers For Rs 1,160 Crore Glenmark Life Sciences' IPO
The IPO comprises a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73.05 lakh equity shares by Glenmark Pharmaceuticals.
-
Stocks To Watch: HDFC Bank, Macrotech Developers, Glenmark Pharma
HDFC Bank reported net profit of Rs 8,186.51 crore in the January-March quarter, an increase of 18.2 per cent compared to Rs 6,927.69 crore during the same period last year
-
Glenmark Life Sciences Files IPO Papers With Sebi
Glenmark Life Sciences IPO: The offer will comprise a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version
Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
-
Glenmark Pharma To Sell 75% Stake In Life Sciences To Nirma For $680 Million
Drugmaker Glenmark Pharmaceuticals said on Thursday it would sell a 75% stake in unit Glenmark Life Sciences to detergent maker Nirma for 56.52 billion rupees ($679.84 million).
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Glenmark Pharmaceuticals Gets Final US Approval For Lacosamide Tablet
Homegrown pharma major Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Lacosamide tablet, indicated for prevention and control of seizures.
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
Glenmark Life Sciences IPO Subscribed Nearly 45 Times On Final Day Of Issue
Glenmark Life Sciences' share sale via initial public offering (IPO) was subscribed by 44.17 times on Thursday, July 29- the third and final day of its issue.
-
Glenmark Life Sciences IPO Opens Today
Glenmark Life Sciences IPO, which will be open for three days until July 29, will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares
-
Glenmark Life Sciences IPO To Open Tomorrow. Should You Subscribe?
Glenmark Life Sciences' IPO will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares by Glenmark Pharmaceuticals
-
Glenmark Life Sciences IPO To Open On July 27. Here's All You Need To Know
Glenmark Life Sciences' IPO will consist of a fresh issue of Rs 1,060 crore and an offer for sale of up to 6.30 million shares by Glenmark Pharmaceuticals
-
Stocks To Watch: HDFC Bank, Wipro, Bank of Baroda
The Reserve Bank of India has imposed a Rs 10 crore penalty on HDFC Bank in relation to marketing and sale of third-party non-financial products to customers, HDFC Bank said
-
Glenmark Arm Files Papers For Rs 1,160 Crore Glenmark Life Sciences' IPO
The IPO comprises a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73.05 lakh equity shares by Glenmark Pharmaceuticals.
-
Stocks To Watch: HDFC Bank, Macrotech Developers, Glenmark Pharma
HDFC Bank reported net profit of Rs 8,186.51 crore in the January-March quarter, an increase of 18.2 per cent compared to Rs 6,927.69 crore during the same period last year
-
Glenmark Life Sciences Files IPO Papers With Sebi
Glenmark Life Sciences IPO: The offer will comprise a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version
Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
